236 related articles for article (PubMed ID: 16626582)
81. [Partial deletion of alpha-galactosidase A gene in a Japanese mutant of Fabry disease].
Sakuraba H; Bishop DF; Suzuki T; Suzuki Y; Desnick RJ
No To Hattatsu; 1990 May; 22(3):247-52. PubMed ID: 2163664
[TBL] [Abstract][Full Text] [Related]
82. Novel sequence variants of the alpha-galactosidase A gene in patients with Fabry disease.
Erdos M; Németh K; Tóth B; Constantin T; Rákóczi E; Ponyi A; Dajnoki A; Grubits J; Pintér I; Garzuly F; Hahn K; Bencsik K; Vécsei L; Fekete G; Maródi L
Mol Genet Metab; 2008 Dec; 95(4):224-8. PubMed ID: 18849176
[TBL] [Abstract][Full Text] [Related]
83. Identification of a novel nonsense mutation in α-galactosidase A that causes Fabry disease in a Chinese family.
Peng Y; Pan M; Wang Y; Shen Z; Xu J; Xiong F; Xiao H; Miao Y
Ren Fail; 2024 Dec; 46(2):2362391. PubMed ID: 38847497
[TBL] [Abstract][Full Text] [Related]
84. Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG).
Ashton-Prolla P; Ashley GA; Giugliani R; Pires RF; Desnick RJ; Eng CM
Am J Med Genet; 1999 Jun; 84(5):420-4. PubMed ID: 10360396
[TBL] [Abstract][Full Text] [Related]
85. A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene.
Tuttolomondo A; Duro G; Pecoraro R; Simonetta I; Miceli S; Colomba P; Zizzo C; Di Chiara T; Scaglione R; Della Corte V; Corpora F; Pinto A
Clin Biochem; 2015 Jan; 48(1-2):55-62. PubMed ID: 25281798
[TBL] [Abstract][Full Text] [Related]
86. High variability of Fabry disease manifestations in an extended Italian family.
Cammarata G; Fatuzzo P; Rodolico MS; Colomba P; Sicurella L; Iemolo F; Zizzo C; Alessandro R; Bartolotta C; Duro G; Monte I
Biomed Res Int; 2015; 2015():504784. PubMed ID: 25977923
[TBL] [Abstract][Full Text] [Related]
87. Identification of mutations in Colombian patients affected with Fabry disease.
Uribe A; Mateus HE; Prieto JC; Palacios MF; Ospina SY; Pasqualim G; da Silveira Matte U; Giugliani R
Gene; 2015 Dec; 574(2):325-9. PubMed ID: 26297554
[TBL] [Abstract][Full Text] [Related]
88. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R
Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550
[TBL] [Abstract][Full Text] [Related]
89. Fabry's disease with LVOT obstruction: diagnosis and management.
Blount JR; Wu JK; Martinez MW
J Card Surg; 2013 Nov; 28(6):695-8. PubMed ID: 23992477
[TBL] [Abstract][Full Text] [Related]
90. Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.
Eng CM; Ashley GA; Burgert TS; Enriquez AL; D'Souza M; Desnick RJ
Mol Med; 1997 Mar; 3(3):174-82. PubMed ID: 9100224
[TBL] [Abstract][Full Text] [Related]
91. A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy.
Al-Thihli K; Ebrahim H; Hughes DA; Patel M; Tipple M; Salvarinova R; Gardiner J; Vallance H; Waters PJ
Gene; 2012 Apr; 497(2):320-2. PubMed ID: 22336178
[TBL] [Abstract][Full Text] [Related]
92. Clinical, histological and molecular characteristics of Mexican patients with Fabry disease and significant renal involvement.
Ramos-Kuri M; Olvera D; Morales JJ; Rodriguez-Espino BA; Lara-Mejía A; De Los Ríos D; Obrador GT; Granados J; Correa-Rotter R
Arch Med Res; 2014 Apr; 45(3):257-62. PubMed ID: 24656905
[TBL] [Abstract][Full Text] [Related]
93. [Pedigree investigation of clinicopathologic features and alpha-galactosidase A gene mutation in a family with Fabry disease].
Liu XX; Yu CW; Yang Y; Hu ZX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):948-51. PubMed ID: 23387234
[TBL] [Abstract][Full Text] [Related]
94. Diagnostic dilemma: a young woman with Fabry disease symptoms, no family history, and a "sequencing cryptic" α-galactosidase a large deletion.
Feldt-Rasmussen U; Dobrovolny R; Nazarenko I; Ballegaard M; Hasholt L; Rasmussen AK; Christensen EI; Sorensen SS; Wibrand F; Desnick RJ
Mol Genet Metab; 2011 Nov; 104(3):314-8. PubMed ID: 21641253
[TBL] [Abstract][Full Text] [Related]
95. The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.
Ferreira S; Ortiz A; Germain DP; Viana-Baptista M; Caldeira-Gomes A; Camprecios M; Fenollar-Cortés M; Gallegos-Villalobos Á; Garcia D; García-Robles JA; Egido J; Gutiérrez-Rivas E; Herrero JA; Mas S; Oancea R; Péres P; Salazar-Martín LM; Solera-Garcia J; Alves H; Garman SC; Oliveira JP
Mol Genet Metab; 2015 Feb; 114(2):248-58. PubMed ID: 25468652
[TBL] [Abstract][Full Text] [Related]
96. Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy.
Sadasivan C; Chow JTY; Sheng B; Chan DKH; Fan Y; Choi PCL; Wong JKT; Tong MMB; Chan TN; Fung E; Kam KKH; Chan JYS; Chi WK; Paterson DI; Senaratne M; Brass N; Oudit GY; Lee APW
PLoS One; 2020; 15(9):e0239675. PubMed ID: 32987398
[TBL] [Abstract][Full Text] [Related]
97. Pedigree analysis of Mexican families with Fabry disease as a powerful tool for identification of heterozygous females.
Gutiérrez-Amavizca BE; Orozco-Castellanos R; R Padilla-Gutiérrez J; Valle Y; Figuera LE
Genet Mol Res; 2014 Aug; 13(3):6752-8. PubMed ID: 25177955
[TBL] [Abstract][Full Text] [Related]
98. Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy.
Ackerman MJ; Landstrom AP
J Am Coll Cardiol; 2007 Dec; 50(25):2404-5. PubMed ID: 18154966
[No Abstract] [Full Text] [Related]
99. Application of Genetic Testing in Unveiling the Diagnosis of Fabry Disease in a Patient with Hypertrophic Cardiomyopathy.
Gedela M; Sharma R; DeBerg K; Stanton C
S D Med; 2021 Apr; 74(4):150-152. PubMed ID: 34432960
[TBL] [Abstract][Full Text] [Related]
100. Cost Efficacy of α-Galactosidase A Enzyme Screening for Fabry Disease.
Newman DB; Miranda WR; Matern D; Peck DS; Geske JB; Maleszewski JJ; Ommen SR; Ackerman MJ
Mayo Clin Proc; 2019 Jan; 94(1):84-88. PubMed ID: 30611458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
